Literature DB >> 11028689

Electrophysiologically guided ablation of the pulmonary veins for the curative treatment of atrial fibrillation.

D C Shah1, M Haïssaguerre, P Jaïs, M Hocini, T Yamane, I Deisenhofer, S Garrigue, J Clémenty.   

Abstract

Catheter ablation of triggers that induce paroxysms of atrial fibrillation (AF) is an emerging curative therapy for this most common of supraventricular arrhythmias. In a series of 225 consecutive patients with multidrug resistant AF, 96% of triggering foci originated from one or several pulmonary veins (PV) independent of ambient ectopy or structural heart disease. This article describes an ablation procedure that is guided by activation mapping tailored to each individual PV, including criteria to define an arrhythmogenic PV, the use of provocative manoeuvres, the role of circumferential mapping catheters to provide information on the extent, distribution and activation of PV muscle as well as the monitoring of distal PV potentials (PVP) during ablation. Radiofrequency ablation to eliminate distal PVPs is performed by targeting the proximal PVP during sinus rhythm (right PV) or left atrial pacing (left PV). This end-point predicts a successful outcome more often than acute ectopy suppression. Complete elimination of AF is presently achieved in 70% of the patients, resulting in the elimination of antiarrhythmic treatment and suspension of anticoagulant treatment. It is anticipated that continued technological development will improve and facilitate this technique of curative treatment of AF.

Entities:  

Mesh:

Year:  2000        PMID: 11028689     DOI: 10.3109/07853890008995948

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  7 in total

1.  Interdisciplinary strategies for arrhythmia program development: measuring quality, performance, and outcomes.

Authors:  N A Mark Estes; Munther Homoud; Jonathan Weinstock; Caroline Foote; Ania Garlitski; Mark Link; Afshin Ehsan
Journal:  J Interv Card Electrophysiol       Date:  2011-03-12       Impact factor: 1.900

2.  Pulmonary vein ablation for idiopathic atrial fibrillation: six month outcome of first procedure in 100 consecutive patients.

Authors:  J P Bourke; A Dunuwille; D O'Donnell; S Jamieson; S S Furniss
Journal:  Heart       Date:  2005-01       Impact factor: 5.994

3.  MDCT in the diagnostic algorithm in patients with symptomatic atrial fibrillation.

Authors:  Christian Sohns; Dirk Vollmann; Lars Luethje; Marc Dorenkamp; Joachim Seegers; Jan D Schmitto; Markus Zabel; Silvia Obenauer
Journal:  World J Radiol       Date:  2011-02-28

4.  Pulmonary vein re-isolation for atrial fibrillation using duty-cycled phased radiofrequency ablation: safety and efficacy of a primary 2:1 bipolar/unipolar ablation mode.

Authors:  Marcus Wieczorek; Reinhard Hoeltgen; Shahram Tajtaraghi; Wolfgang Lawrenz; Michael Lukat
Journal:  J Interv Card Electrophysiol       Date:  2012-10-25       Impact factor: 1.900

Review 5.  Modern management of arrhythmias.

Authors:  M C S Hall; D M Todd
Journal:  Postgrad Med J       Date:  2006-02       Impact factor: 2.401

6.  Atrial Fibrillation.

Authors:  Jayant Bagai; Boaz Avitall
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-08

7.  Comparison of two different doses of single bolus steroid injection to prevent atrial fibrillation recurrence after radiofrequency catheter ablation.

Authors:  Da-Rae Kim; Hoyoun Won; Jae-Sun Uhm; Jong-Youn Kim; Jung-Hoon Sung; Hui-Nam Pak; Moon-Hyoung Lee; Boyoung Joung
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.